160 related articles for article (PubMed ID: 24141503)
1. Cerebrospinal fluid approach on neuro-oncology.
Gomes HR
Arq Neuropsiquiatr; 2013 Sep; 71(9B):677-80. PubMed ID: 24141503
[TBL] [Abstract][Full Text] [Related]
2. Diagnostic strategies to investigate cerebrospinal fluid involvement in haematological malignancies.
Galati D; Di Noto R; Del Vecchio L
Leuk Res; 2013 Mar; 37(3):231-7. PubMed ID: 23287431
[TBL] [Abstract][Full Text] [Related]
3. Cerebrospinal Fluid Flow Cytometry: Utility in Central Nervous System Lymphoma Diagnosis.
Au KLK; Latonas S; Shameli A; Auer I; Hahn C
Can J Neurol Sci; 2020 May; 47(3):382-388. PubMed ID: 32228724
[TBL] [Abstract][Full Text] [Related]
4. CXCL13 and CXCL12 in central nervous system lymphoma patients.
Fischer L; Korfel A; Pfeiffer S; Kiewe P; Volk HD; Cakiroglu H; Widmann T; Thiel E
Clin Cancer Res; 2009 Oct; 15(19):5968-73. PubMed ID: 19773382
[TBL] [Abstract][Full Text] [Related]
5. Cerebrospinal fluid lactate dehydrogenase isoenzyme analysis for the diagnosis of central nervous system involvement in hematooncologic patients.
Lossos IS; Breuer R; Intrator O; Lossos A
Cancer; 2000 Apr; 88(7):1599-604. PubMed ID: 10738218
[TBL] [Abstract][Full Text] [Related]
6. Antithrombin III is probably not a suitable biomarker for diagnosis of primary central nervous system lymphoma.
Kuusisto ME; Haapasaari KM; Remes AM; Bloigu R; Karihtala P; Turpeenniemi-Hujanen T; Kuittinen O
Ann Hematol; 2015 Jul; 94(7):1167-74. PubMed ID: 25697593
[TBL] [Abstract][Full Text] [Related]
7. Diagnostic tools for neoplastic meningitis: detecting disease, identifying patient risk, and determining benefit of treatment.
Chamberlain MC; Glantz M; Groves MD; Wilson WH
Semin Oncol; 2009 Aug; 36(4 Suppl 2):S35-45. PubMed ID: 19660682
[TBL] [Abstract][Full Text] [Related]
8. D-dimer levels in the cerebrospinal fluid: a marker of central nervous system involvement in neoplastic disease.
Eclache V; Vu T; Le Roux G
Nouv Rev Fr Hematol (1978); 1994 Aug; 36(4):321-4. PubMed ID: 7971253
[TBL] [Abstract][Full Text] [Related]
9. Significance of cerebrospinal fluid sIL-2R level as a marker of CNS involvement in acute lymphoblastic leukemia.
Lee W; Kim SJ; Lee S; Kim J; Kim M; Lim J; Kim Y; Cho B; Lee EJ; Han K
Ann Clin Lab Sci; 2005; 35(4):407-12. PubMed ID: 16254256
[TBL] [Abstract][Full Text] [Related]
10. A systematic approach to the diagnosis of suspected central nervous system lymphoma.
Scott BJ; Douglas VC; Tihan T; Rubenstein JL; Josephson SA
JAMA Neurol; 2013 Mar; 70(3):311-9. PubMed ID: 23319132
[TBL] [Abstract][Full Text] [Related]
11. Utility of flow cytometry of cerebrospinal fluid as a screening tool in the diagnosis of central nervous system lymphoma.
Pittman M; Treese S; Chen L; Frater JL; Nguyen TT; Hassan A; Kreisel F
Arch Pathol Lab Med; 2013 Nov; 137(11):1610-8. PubMed ID: 24168498
[TBL] [Abstract][Full Text] [Related]
12. Cerebrospinal fluid beta-2-microglobulin in adult patients with acute leukemia or lymphoma: a useful marker in early diagnosis and monitoring of CNS-involvement.
Hansen PB; Kjeldsen L; Dalhoff K; Olesen B
Acta Neurol Scand; 1992 Mar; 85(3):224-7. PubMed ID: 1575009
[TBL] [Abstract][Full Text] [Related]
13. How to facilitate early diagnosis of CNS involvement in malignant lymphoma.
Korfel A; Nowosielski M; Pardo-Moreno J; Penalver FJ; Buda G; Bennani H; Costopoulos M; Le Garff-Tavernier M; Soussain C; Schmid M; Orfao JA; Glantz M
Expert Rev Hematol; 2016 Nov; 9(11):1081-1091. PubMed ID: 27677656
[TBL] [Abstract][Full Text] [Related]
14. CSF neopterin level as a diagnostic marker in primary central nervous system lymphoma.
Viaccoz A; Ducray F; Tholance Y; Barcelos GK; Thomas-Maisonneuve L; Ghesquières H; Meyronet D; Quadrio I; Cartalat-Carel S; Louis-Tisserand G; Jouanneau E; Guyotat J; Honnorat J; Perret-Liaudet A
Neuro Oncol; 2015 Nov; 17(11):1497-503. PubMed ID: 26014047
[TBL] [Abstract][Full Text] [Related]
15. [Diagnosis, prophylaxis and treatment of central nervous system involvement by non-Hodgkin lymphoma in HIV-infected patients].
Miralles P; Berenguer J; Ribera JM;
Med Clin (Barc); 2010 Sep; 135(9):417-22. PubMed ID: 19628233
[TBL] [Abstract][Full Text] [Related]
16. Autotaxin and soluble IL-2 receptor concentrations in cerebrospinal fluids are useful for the diagnosis of central nervous system invasion caused by haematological malignancies.
Shimura T; Kurano M; Morita Y; Yoshikawa N; Nishikawa M; Igarashi K; Shimamoto S; Aoki J; Yatomi Y
Ann Clin Biochem; 2019 Mar; 56(2):240-246. PubMed ID: 30514094
[TBL] [Abstract][Full Text] [Related]
17. Case series: CSF LDH, proteins and electrolyte levels in patients of acute lymphocytic leukemia.
Rao D; Ghalaut VS; Ghalaut PS; Rao S
Clin Chim Acta; 2012 Jul; 413(13-14):1045-8. PubMed ID: 22387722
[TBL] [Abstract][Full Text] [Related]
18. Detection of malignant hematopoietic cells in cerebral spinal fluid previously diagnosed as atypical or suspicious.
Schinstine M; Filie AC; Wilson W; Stetler-Stevenson M; Abati A
Cancer; 2006 Jun; 108(3):157-62. PubMed ID: 16649227
[TBL] [Abstract][Full Text] [Related]
19. CSF and clinical data are useful in differentiating CNS inflammatory demyelinating disease from CNS lymphoma.
Ikeguchi R; Shimizu Y; Shimizu S; Kitagawa K
Mult Scler; 2018 Aug; 24(9):1212-1223. PubMed ID: 28657431
[TBL] [Abstract][Full Text] [Related]
20. Utility and proposed algorithm of CSF flow cytometry in hematologic malignancies.
Tawfik B; Brown L; Fuda F; Chen W; Niu S; Sailors J; Sadeghi N
Ann Hematol; 2018 Sep; 97(9):1707-1716. PubMed ID: 29680874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]